Regeneron Pharmaceuticals, Inc.; Inc.;University Health Network (UHN);Regeneron Pharmaceuticals
发明人:
Purcell Ngambo, Lisa Arleen,Higgins, Sarah J.,Kain, Kevin C.
申请号：
AU2014342162
公开号：
AU2014342162A1
申请日:
2014.10.31
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
